BOTHELL, Wash. & TEWKSBURY, Mass.--(BUSINESS WIRE)--Cardiac Science Corporation [NASDAQ: CSCX], a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, and Cambridge Heart, Inc., [OTCBB-CAMH], a developer of noninvasive diagnostic tests for cardiac disease, with a focus on identifying those at risk for sudden cardiac arrest, today announced a partnership pursuant to a Development, Supply and Distribution Agreement Cambridge Heart previously announced on June 23, 2009. Under the Agreement, the Companies are collaborating to develop a Microvolt T-Wave Alternans (MTWA) module, which will be integrated with Cardiac Science’s cardiac stress test systems.
